Viewing Study NCT01102595


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-01-01 @ 6:16 AM
Study NCT ID: NCT01102595
Status: COMPLETED
Last Update Posted: 2015-08-26
First Post: 2010-04-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
Sponsor: Grupo Español de Investigación en Neurooncología
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module